NCT04115410 2020-05-28PD-1 Immune Checkpoint Inhibitors and Immune-Related Adverse Events: a Cohort StudySungkyunkwan UniversityUnknown4,724 enrolled
NCT00644020 2008-03-26Phase â…¡Study of Tyroserleutide for Injection in Hepatocellular Carcinoma(HCC) PatientsShenzhen Kangzhe Pharmaceutical Co., Ltd.Unknown100 enrolled